Suriname

Medicines regulation in Suriname is overseen by the Ministry of Health, Welfare and Labour, with packaged medicines registered through the Registratie Commissie and pharmaceutical oversight supported by the Farmaceutische Inspectie. The Commission’s Dutch-language page identifies the national legal basis for registration and explains the role of the medicines register. The Ministry also publishes current instructions for submitting registration dossiers and import-permit applications. Applicants and local suppliers should maintain suitable post-market arrangements to collect and evaluate complaints and suspected adverse reactions, communicate important safety or quality issues to the competent authorities, keep product information current and comply with any safety conditions imposed during registration or importation. However, the accessible official Surinamese material does not clearly publish a comprehensive national GVP guideline or universal numerical requirements for a local QPPV, PSMF, post-marketing ICSR timelines, fixed PSUR/PBRER frequencies, a national RMP format or a routine PV-inspection cycle applicable to every product. Those obligations should therefore be confirmed with the Registratie Commissie and Farmaceutische Inspectie for the relevant product rather than inferred from EU, Dutch or Caribbean systems. BAUPHARMA supporting resources (operational context only, not national regulatory evidence): Effective Signal Management in Pharmacovigilance.